Private Practices Face Challenges Recruiting Young Urologists
Urology trainees today say they prefer to be employed in academic or hospital settings and favor a better work/life balance over compensation.
LUGPA
Biden Presidency May Affect LUGPA’s Advocacy Efforts
Joe Biden’s administration could bring new leadership at the Centers for Medicare and Medicaid Services, possibly presenting more challenges influencing regulations.
Alternative Treatments for NMIBC Urged Amid BCG Shortages
Urologists must ration use of BCG and opt for alternative intravesical treatments when possible
Avoiding Litigation by Knowing How to Deal With Angry Patients
Physicians can take steps to reduce their risk of being sued by having a low threshold for discharging angry patients from their practice and carefully documenting all discussions and interactions with these patients.
Mitomycin Gel for Low-Grade Upper Tract Urothelial Carcinoma
Mitomycin gel (Jelmyto), which received FDA approval in April 2020, addresses a need for a better way to treat low-grade UTUC, a malignancy that is challenging to manage.
Open Mic Discussion at LUGPA: What Keeps You Up at Night?
An open mic session brought physicians and administrations to discuss their challenges and brainstorm solutions.
Defending Group Practices Against Cyber Threats
A security expert outlined the most common risks that group practices face and strategies to prevent them from occurring.
Private Equity Debated at LUGPA
Whether private equity is right for a group depends on multiple factors.
Jeb Bush Discusses Politics and More at LUGPA
Jeb Bush delivers keynote address at the Large Urology Group Practice Association annual meeting.
LUGPA Health Policy Forum Highlights Wins, Setbacks, and Ongoing Advocacy Struggles
LUGPA Health Policy Forum details list of wins and setbacks that LUGPA has had in advocating for pricing and reimbursement policies with the CMS.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in LUGPA 2019 Annual Meeting
Loading... 
Loading...